SURFACE MARKERS AND GENE EXPRESSION TO CHARACTERIZE THE DIFFERENTIATION OF MONOLAYER EXPANDED HUMAN ARTICULAR CHONDROCYTES by HAMADA, TAKASHI et al.
101
ORIGINAL PAPER
Nagoya J. Med. Sci. 75. 101 ~ 111, 2013
SURFACE MARKERS AND GENE EXPRESSION 
TO CHARACTERIZE THE DIFFERENTIATION OF 
MONOLAYER EXPANDED HUMAN ARTICULAR 
CHONDROCYTES
TAKASHI HAMADA1, TADAHIRO SAKAI1, HIDEKI HIRAIWA1, MOTOSHIGE NAKASHIMA1,  
YOHEI ONO1,2, HIROHITO MITSUYAMA3 and NAOKI ISHIGURO1
1Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan 
2Department of Anatomy and Cell Biology, Brody School of Medicine,  
East Carolina University, 600 Moye Blvd. Greenville, NC 27834, USA 
3Nagoya Grampus Clinic, Toyota, Japan
ABSTRACT
Autologous chondrocyte implantation (ACI) is a method of cartilage repair. To improve the quality 
of regenerated tissue by ACI, it is essential to identify surface marker expression correlated with the 
differentiation status of monolayer expanded human articular chondrocytes and to define the index for 
discriminating dedifferentiated cells from monolayer expanded human articular chondrocytes. Normal human 
articular chondrocytes were cultured in monolayer until passage 4. At each passage, mRNA expression of 
collagen type I, II, and X and aggrecan was analyzed by real-time quantitative PCR, and the surface marker 
expression of CD14, CD26, CD44, CD49a, CD49c, CD54, and CD151 was analyzed by fluorescence-
activated cell sorting (FACS). The ratios of mRNA levels of collagen type II to I (Col II/Col I) represented 
the differentiation status of chondrocytes more appropriately during monolayer culture. The surface marker 
expression of CD44, CD49c, and CD151 was upregulated according to the dedifferentiation status, whereas 
that of CD14, CD49a, and CD54 was downregulated. The most appropriate combination of the ratio of Col 
II/Col I was CD54 and CD44. Cell sorting was performed using a magnetic cell sorting system (MACS) 
according to CD54 and CD44, and real-time quantitative PCR was performed for the cell subpopulations 
before and after cell sorting. The expression of collagen type II and aggrecan of the chondrocytes after 
MACS was higher than that before sorting, but not significantly. The mean fluorescence intensity (MFI) 
ratio of CD54 to CD44 could be an adequate candidate as the index of the differentiation status.
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INTRODUCTION
The treatment of cartilage defects in younger patients is a major challenge for surgeons because 
articular cartilage has limited potential of intrinsic repair.1) Two strategies have been considered 
for the restoration of the joint surface. The first approach is to enhance the intrinsic healing 
capacity of both the cartilage and subchondral bone through the release of mesenchymal stem 
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cells involving procedures such as subchondral drilling,2) microfracture,3) abrasion arthroplasty,4,5) 
electrical stimulation,6) and laser stimulation.7) These methods have generally led to the formation 
of fibrocartilage, which has limited functionality than hyaline articular cartilage. An alternative 
approach is to repair the hyaline articular cartilage, particularly suited to younger patients. This 
approach involves the use of tissue engineering strategies to elicit a biological repair that has 
long-term functionality. Meanwhile, cartilage tissue engineering relies on in vitro expansion of 
primary chondrocytes. Monolayer expansion of primary chondrocytes from small biopsies is 
very important in cartilage repair strategies such as autologous chondrocyte implantation (ACI). 
There have been many reports of successful cartilage defect repair by ACI.8-11) In the US and 
Europe, variants of ACI have also been tried in approximately 10,000 patients.12) This method 
requires an in vitro cell expansion process to obtain a large number of transplantable chondrocytes 
for fulfilling the cartilage defect. However, cell expansion using monolayer cell culture causes 
chondrocytes to lose their phenotype, e.g., switching their gene expression from the cartilage-
specific collagen type II to collagen type I13) or decreasing the production of proteoglycans such 
as aggrecan.14) Normal adult hyaline articular cartilage usually does not contain collagen type X, 
markers of chondrocyte hypertrophy15); however, the expression of collagen type X is observed 
during monolayer culture.16) In addition, it is thought that during monolayer expansion, human 
articular chondrocytes change with respect to their cell surface marker expression.17) Human 
articular chondrocytes reportedly express surface molecules belonging to different categories 
such as integrins, other adhesion molecules, tetraspanins, receptors, and ectoenzymes that induce 
changes in the expression levels during monolayer expansion.17) Otherwise, graft hypertrophy is 
a major complication observed in ACI.18) It has been strongly suggested that dedifferentiation of 
chondrocytes affects the quality of the cartilage regenerated by ACI. Although midterm clinical 
results of ACI are satisfactory, hyaline cartilage that should be related to long-term results is 
not regenerated thoroughly till date. To improve the quality of the regenerated tissue by ACI, it 
could be essential to discriminate dedifferentiated cells from monolayer expanded human articular 
chondrocytes by using some index related to the surface markers.
On the other hand, the technique of cell sorting using antibodies to cell surface markers can 
be reportedly used in various fields of medicine.19-21) However, the technique of sorting was hardly 
put for the practical use in the field of the cartilage tissue regeneration till date.22)
This study aimed to identify surface marker expression correlated with the differentiation status 
of monolayer expanded human articular chondrocytes and to define the index for discriminating 
dedifferentiated cells from monolayer expanded human articular chondrocytes.
MATERIALS AND METHODS
Cell culture
Human articular cartilage (HAC) samples were obtained at the time of joint surgery for loose 
body removal from patients who suffered from osteochondritis dissecans or notchplasty of the 
intercondylar roof of the femur from patients who underwent anterior cruciate ligament recon-
struction. The patients included three women and two men, with a mean age of 29.4 years (range 
17–40 years). None of them showed any symptoms related to osteoarthritis. These experiments 
were conducted in accordance with a protocol approved by the Ethics Committee of Nagoya 
University, and all the patients gave written consent for the use of their tissues for this research.
Cartilage samples were minced and digested at 37°C with trypsin–EDTA solution (Sigma, 
MO, USA) for 15 min, with collagenase type XI (2 mg/ml) (Sigma) in F-12 nutrient mixture 
medium (Gibco-BRL, Belgium) for 12 h, filtered through a 70-μm nylon mesh, and washed 
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extensively. Following this, the isolated chondrocytes were seeded in 75-cm2 culture flasks and 
were incubated in F-12 nutrient mixture medium containing 10% fetal bovine serum, penicillin 
(100 units/ml), streptomycin (100 mg/ml), amphotericin B (2.5 μg/ml), and ascorbic acid (0.2 
mM) at 37°C under an atmosphere of 5% CO2. The medium was changed every second day. 
At 80% confluence, the cells [considered passage zero (P0) cells] were detached and expanded 
in monolayer culture by replating the cells in a 10-cm tissue culture dish with culture medium. 
The cells were passaged at subconfluence until passage 4 (P4). The cells from each passage 
were used in subsequent experiments.
Real-time quantitative polymerase chain reaction
Total RNA was extracted using the RNeasy Kit (Qiagen, Hilden, Germany) in accordance with 
the manufacturer’s instructions. RNA was converted to cDNA using the High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). Real-time polymerase 
chain reaction (PCR) was performed in a LightCycler (Roche, Basel, Switzerland) using the 
FastStart DNA MasterPLUS SYBR Green Kit (Roche). The primers used are listed in Table 
1. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an endogenous control. 
Standard samples were prepared from the PCR amplicon extracted using the QIAquick Gel 
Extraction Kit (Qiagen Inc.). The standard curve was imported to each PCR run by the software 
to determine the concentration of the samples. All data were normalized, and the value for the 
sample at P0 was 100%.
Immunofluorescence staining of chondrocytes and fluorescence-activated cell sorting
All monoclonal antibodies (mAbs) used in this study (Table 2) were directly conjugated 
antibodies to fluorescein isothiocyanate (mAb-FITC) or to phycoerythrin (mAb-PE).
The cells were analyzed on a fluorescence-activated cell sorter, FACSCalibur flow cytometer 
(Becton-Dickinson, San Jose, CA, USA). Data analysis was performed with CellQuest software 
(Becton-Dickinson).
The level of expression of each marker was the analyzed geometric mean fluorescence intensity 
(MFI) of sample cells. To determine changes in surface markers during monolayer culture, fold 
changes of the levels of expression of a marker at different time points (P1–P4) were calculated 
in relation to P0 (beginning of the culture), and a two-tailed, unpaired Student’s t-test was 
performed for the same data. A significant change in expression was defined as a fold change 
Table 1 Primer sequence
(GAPDH, glyceraldehyde-3-phosphate dehydrogenase)
GAPDH 
Sense 5′-TGCACCACCAACTGCTTAGC-3′ 
Antisense 5′-GGCATGGACTGTGGTCATGAG-3′ 
collagen type I 
Sense 5′-CCTCAAGGGCTCCAACGAG-3′ 
Antisense 5′-TCAATCACTGTCTTGCCCCA-3′ 
collagen type II 
Sense 5′-TGGAGACTGGCGAGACTT-3′ 
Antisense 5′-TGGGAGCCAGATTGTCATC-3′ 
aggrecan 
Sense 5′-CCAGGAGGTATGTGAGGA-3′ 
Antisense 5′-CGATCCACTGGTAGTCTTG-3′ 
collagen type X 
Sense 5′-ATGCATATGGAGGTAGGCT-3′ 
Antisense 5′-AGAGAGGCTTCACATACGTT-3′ 
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of greater than two with a P value < 0.05.
Cell sorting
Cell sorting was performed using a magnetic cell sorting system (MACS) according to the 
manufacturer’s instructions (Miltenyi Biotech, Bergisch Gladbach, Germany). 
P2 monolayer expanded human articular chondrocytes were prepared as single-cell suspensions. 
To obtain CD44−CD54+ cells, the suspensions were incubated with FITC-anti-CD44 (Abcam, 
Tokyo, Japan), followed by incubation with anti-FITC microbeads (Miltenyi Biotec). CD44− cells 
were negatively selected using MACS. The flow-through cells (considered CD44− cells) were sec-
ondary incubated with PE-anti-CD54 antibodies (BD Pharmingen, San Jose, CA, USA), followed 
by incubation with anti-PE microbeads (Miltenyi Biotec). Subsequently, CD44−CD54+ cells were 
positively selected using MACS. Purity of the isolated fraction was verified by FACS analysis.
RESULTS
The ratios of mRNA levels of collagen type II to I (Col II/Col I) represented the differentiation 
status of chondrocytes more appropriately during monolayer culture
To investigate the change in the phenotype of human articular chondrocytes, real-time quantita-
tive PCR was performed at each time point during monolayer culture. 
The expression of collagen type II and aggrecan decreased in a passage-dependent manner 
(Figure 1a, b). In contrast, the expression of collagen type I increased (Figure 1c). However, 
a significant change was not observed in the expression of collagen type X (Figure 1d). To 
examine which combination of changes in gene expression of the extracellular matrix components 
will represent the differentiation status of HAC more clearly, we calculated the ratios of mRNA 
levels of collagen type II to I (Col II/Col I) and of aggrecan to collagen type I (Agg/Col I) 
(Figure 2). These results showed that the ratio of collagen type II to type I seemed to represent 
the dedifferentiation status of chondrocytes more appropriately than that of aggrecan to collagen 
type I as an extracellular matrix-based differentiation index. It was also revealed that the ratio 
of Col II/Col I showed the maximum change at the beginning of the culture period (P0–P1).
Immunophenotyping of HAC during monolayer culture
To investigate changes in cell surface markers during chondrocyte monolayer culture, we 
analyzed cell surface molecule expression levels at different time points by flow cytometry.
CD44, CD49c, and CD151 were up-regulated according to the dedifferentiation status, whereas 
CD14, CD49a, and CD54 were down-regulated. Most surface markers showed major changes at 
Table 2 Antibodys used in the present study
Specificity Isotype cat.# Fluochrome Source
CD14 IgG2a 555397 FITC BD Pharmingen
CD26 IgG2a′ 340426 FITC BD Pharmingen
CD44 IgG1 ab27285 FITC abcam
CD49a IgG1 559596 PE BD Pharmingen
CD49c IgG1 556025 PE BD Pharmingen
CD54 IgG1 555511 PE BD Pharmingen
CD151 IgG1 556057 PE BD Pharmingen
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Fig. 1 Chondrocyte mRNA levels for collagen type II (a), aggrecan (b), collagen type I (c) and collagen 
type X (d) at different time points in monolayer culture, as measured by real-time, quantitative 
RT-PCR. Values are expressed as fold differences compared to levels in P0. The results are shown 
as mean ± SEM (error bars) from three donors for each passage. Differences when compared 
to P0 considered statistically significant (P < 0.05) are indicated (*).
Fig. 2 Ratios for collagen type II to I (Col II/Col I) and aggrecan to collagen type I (Agg/Col I) 
were obtained from chondrocyte mRNA levels at different time points in monolayer culture as 
measured by real-time, quantitative RT-PCR (qRT-PCR). The results are shown as mean ± SEM 
(error bars) from three donors for each passage. Differences when compared to P0 considered 
statistically significant (P < 0.05) are indicated (*).
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the beginning of the culture period (P0–P1), with small variations for the remaining time course. 
No significant change was observed in the expression of CD26 (Figure 3a-g).
Interrelationship between gene expression and surface marker expression
To correlate changes in gene expression of the extracellular matrix components with the 
established changes in cell surface markers during chondrocyte monolayer culture, we calculated 
the MFI ratio of each down-regulated cell surface marker (CD14, CD49a, and CD54) to each 
up-regulated marker (CD44, CD49c, and CD151). Subsequently, we compared the extracellular 
matrix-based differentiation index (Col II/Col I) with a differentiation index based on the cell 
surface markers. As a result, the most appropriate combination of the ratio of Col II/Col I was 
CD54 and CD44 (CD54/CD44) (Figure 4).
The results revealed dramatic changes occurring as early as the first passage. The Col II/Col 
I ratio steadily declined until the end of the culture. A similar pattern was observed for the ratio 
of CD54/CD44. Therefore, it was suggested that a positive interrelationship was present between 
the expression of surface markers (CD54/CD44) and the dedifferentiation status of monolayer 
expanded human articular chondrocytes.
Flow cytometric analysis of HAC sorted by MACS
Next, we conducted cell sorting experiments according to CD54 and CD44 using MACS. 
Figure 5a, b and Figure c, d show the results of flow cytometry of the chondrocytes after MACS 
according to CD54 and CD44, respectively. Purity of isolated CD54+CD44− fraction was 79.9%. 
Fig. 3 Chondrocyte surface marker expressions. MFI levels for CD44 (a), CD49c (b), CD151 (c), CD14 (d), 
CD49a (e), CD54 (f) and CD26 (g) at different time points in monolayer culture. The results are shown 
as mean ± SEM (error bars) from three donors for each passage. Differences when compared to P0 
considered statistically significant (P < 0.05) are indicated (*).
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Fig. 4 Interrelationship between the gene expressions and the surface marker expressions. The results 
are shown as mean ± SEM (error bars) from three donors for each passage.
 Differences when compared to P0 considered statistically significant (P < 0.05) are indicated (*).
Fig. 5 Flow cytometric analysis of HAC sorted by MACS technology. (a) Dot plot before sorting ac-
cording to CD54. (b) CD54 positive fraction after sorting. (c) Dot plot before sorting according 
to CD44. (d) CD44 negative fraction after sorting.
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These results indicated the possibility of discriminating the CD54+CD44− cell subpopulations 
from monolayer expanded human articular chondrocytes using MACS.
Gene expression analysis of HAC comparing before and after cell sorting
To confirm whether the distinguished chondrocytes could have a more advantaged phenotype 
for forming neo-cartilage tissue, we performed real-time quantitative PCR for the cell subpopu-
lations before and after cell sorting. The expression of collagen type II and aggrecan of the 
chondrocytes after MACS tended to be higher than that before sorting, but not significantly 
(Figure 6).
DISCUSSION
Articular cartilage consists of only one cell type: round chondrocytes characterized by their 
ability to produce the main constituents of the hyaline extracellular matrix, namely collagen types 
II, IX, and XI and proteoglycans.23) Chondrocytes can be released from cartilage by enzymatic 
digestion and be expanded in culture, an important step for their clinical application in cell-
based cartilage repair therapies.24,25) However, during serial monolayer culture, the chondrocyte 
phenotype is lost, and cells alter their morphology and metabolism in a process termed dedif-
ferentiation.13,26) While a clear link between chondrocyte dedifferentiation and the differential 
production of extracellular matrix components has been established, the cell surface protein 
composition of chondrocytes during the dedifferentiation process remains poorly understood. 
Uncovering chondrocyte surface proteins are attractive because some of these proteins could be 
used as markers to discriminate between differentiated and dedifferentiated cells or even differ-
ent stages of dedifferentiation.27) The identification of new markers to characterize chondrocyte 
differentiation status based on cell surface marker expression would contribute to cartilage tissue 
engineering, from quality control for cell expansion to the optimization of culture conditions. 
Further validation of these surface molecules as markers of the differentiation status will require 
determination of whether the profile of cell surface proteins induced by monolayer culture can 
be reversed using redifferentiation procedures.
Therefore, in this study, we investigated changes in gene expression and surface marker expres-
sion correlated with the dedifferentiation of monolayer expanded human articular chondrocytes 
Fig. 6 Chondrocyte mRNA levels for collagen type II, aggrecan and collagen type I, before and after cell sorting, 
as measured by real-time, quantitative RT-PCR. Values are expressed as fold differences compared to 
levels before sorting. The results are shown as mean ± SEM (error bars) from three donors for each 
passage. No significant differences are observed, respectively.
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to define the index for cell sorting related to the surface markers.
We compared the extracellular matrix-based differentiation index (Col II/Col I) with a dif-
ferentiation index based on the cell surface markers. As a result, it was suggested that single 
surface marker expression is not appropriate as the index of differentiation because of insuf-
ficiency in the amplitude of changes, whereas the ratio of CD54 to CD44 demonstrates the state 
of differentiation more clearly.
Hyaluronan (HA) is a large glycosaminoglycan composed of repeating disaccharides of D-
glucuronic acid and N-acetyl-glucosamine. Articular chondrocytes constitutively express CD4428) 
and ICAM-1,29) two specific HA receptors.30) There is evidence that those HA receptors biologi-
cally mediate the effects of HA. In contrast, CD44 reportedly has multiple functions beside the 
HA receptor, such as HA endocytosis, cell proliferation, or migration.31-33) While the principal 
HA receptor is CD44,34) ICAM-1 is induced during the inflammatory response and by cytokines 
such as IL-1.35) ICAM-1 is a glycosylated protein of 80–114 KDa with a core polypeptide 
of 55 KDa, and it has an important role in leukocyte trafficking and cell–cell adherence in 
immunological response.36,37) We speculated that the switching of HA receptors on monolayer 
cultured chondrocytes continues along the line of the dedifferentiation status. During monolayer 
culture, it is speculated that chondrocytes tend to be more proliferative instead of losing their 
specific phenotype, resulting in the increased expression of CD44. Simultaneously, the expression 
of ICAM-1 is decreased because the chondrocytes are spreading out to advance their cell–cell 
contact. Consequently, the ratio of ICAM-1 (CD54) and CD44 could be decreased in the dedif-
ferentiation status during monolayer culture.
Then, we performed the cell sorting according to CD54 and CD44 using MACS. In our 
results of real-time quantitative PCR, the expression of collagen type II and aggrecan of the 
chondrocytes after MACS tended to be higher than that before sorting, but not significantly. It 
is speculated that in the cell subpopulations before and after cell sorting that were cultured by 
the technique of redifferentiation such as pellet culture or the other three dimensional culture, 
significant differences could be observed in the expression of the chondrocyte-specific phenotype. 
We are studying whether the distinguished cells from monolayer expanded chondrocytes could 
form better regenerated cartilage tissue in pellet culture or in vivo experiments and by the ACI 
procedure.
There are three problems of cell sorting using MACS technology. First, the number of chon-
drocytes is decreased in comparison after sorting using MACS. Second, whether the magnetic 
beads used in MACS may affect the human body during the ACI procedure remains unknown. 
Third, purity of isolated fraction is not so high. There might be nonspecific binding, because we 
performed the cell sorting in indirect method. Therefore, purity might become relatively low. It 
is necessary to establish the techniques to obtain a higher recovery rate and purity, and further 
experiments are required to investigate the influence of the magnetic beads on the human body 
in vivo.
There are some limitations in this study. Because it is difficult to obtain normal human 
cartilage in Japan mainly on account of religious reasons, the number of samples is small and 
the amount of cartilage tissue is very small. Therefore, we could not conduct sufficient experi-
ments. We speculated that the small number of samples (n = 3) was one of the reasons why 
no significant difference was observed in this experiment (Figure 6). If the number of samples 
would increase, a significant difference could be observed.
In summary, the present study indicates that the ratio of mRNA expression of collagen type 
II to type I represented the differentiation status of human articular chondrocytes. Surface marker 
expression also changed according to the differentiation status. The MFI ratio of CD54 to CD44 
could be an adequate candidate as the index of the differentiation status. Further studies are 
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required to evaluate distinguished chondrocytes could form better cartilage tissue and to confirm 
the usefulness for the ACI procedure.
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